BeStock  
Stocks › Biotechnology › GMAB

Genmab GMAB

US equityMarket cap rank #546Biotechnology
$34.80 −$0.88 (-2.45%)
Market open · Oct 1, 1:20 pm ET · After hours $35.36 -0.88%
Open$35.28
Prev close$35.68
Day range$34.63 – $35.80
Volume3.84M
Market cap$21.72B
P/E (TTM)27.5
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$1.16B+24.9% YoY
Operating profit$407.00M+13.1% YoY
Net profit$303.00M-9.8% YoY
Diluted EPS$0.49-9.4% YoY
Free cash flow$48.00M-7.7% YoY
Operating cash flow$51.00M

Revenue, last 8 quarters

$816.0MSep '24$923.0MDec '24$715.0MMar '25$925.0MJun '25$1.0BSep '25$1.1BDec '25$896.0MMar '26$1.2BJun '26

Net profit, last 8 quarters

$186.0MSep '24$552.0MDec '24$195.0MMar '25$336.0MJun '25$401.0MSep '25$31.0MDec '25$53.0MMar '26$303.0MJun '26

Diluted EPS by quarter

0.29Sep '240.85Dec '240.31Mar '250.54Jun '250.65Sep '250.05Dec '250.08Mar '260.49Jun '26

Free cash flow by quarter

$292.0MSep '24$360.0MDec '24$257.0MMar '25$52.0MJun '25$534.0MSep '25$288.0MDec '25$-2.0MMar '26$48.0MJun '26

Annual revenue

$1.7BFY20$1.3BFY21$2.1BFY22$2.4BFY23$3.1BFY24$3.7BFY25

Profitability & balance sheet

Gross margin93.0%
Operating margin32.3%
Net margin19.1%
Return on equity14.0%
Return on assets8.3%
Return on invested capital10.9%
Current ratio2.46
Liabilities / assets52.4%
Cash & investments$1.50B
Total debt$5.26B
Net cash (debt)-$3.75B
Free cash flow / sales21.0%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $1.16B $896.00M $3.72B $1.06B $1.02B
Total Operating Revenue $1.16B $896.00M $3.72B $1.06B $1.02B
Cost of Revenue $84.00M $65.00M $238.00M $81.00M $58.00M
Gross Profit $1.07B $831.00M $3.48B $977.00M $964.00M
Operating Expense $664.00M $606.00M $2.23B $734.00M $505.00M
Selling and Admin Expenses $205.00M $166.00M $626.00M $208.00M $148.00M
Research & Development $459.00M $440.00M $1.61B $526.00M $357.00M
Operating Profit $407.00M $225.00M $1.25B $243.00M $459.00M
Net Non-Operating Interest Income (Expense) -$74.00M -$98.00M $77.00M $4.00M $29.00M
Non-Operating Interest Income $36.00M $14.00M $138.00M $48.00M $32.00M
Non-Operating Interest Expense $110.00M $112.00M $61.00M $44.00M $3.00M
Other Income (Expense) -$38.00M -$53.00M -$123.00M -$192.00M -$6.00M
Gain on Sale of Security -$6.00M -$8.00M $62.00M -$7.00M -$6.00M
Special Income (Charges) -$32.00M -$45.00M -$185.00M -$185.00M $0.00
-Less:Restructuring and Mergern & Acquisition $32.00M $45.00M $185.00M $185.00M $0.00
Pretax Profit $295.00M $74.00M $1.20B $55.00M $482.00M
Tax -$8.00M $21.00M $241.00M $24.00M $81.00M
Net Profit $303.00M $53.00M $963.00M $31.00M $401.00M
Profit from Continuing Operations $303.00M $53.00M $963.00M $31.00M $401.00M
Net Income to Parent Company $303.00M $53.00M $963.00M $31.00M $401.00M
Net Income to Common Stockholders $303.00M $53.00M $963.00M $31.00M $401.00M
Basic EPS $0.49 $0.08 $1.55 $0.06 $0.65
Diluted EPS $0.49 $0.08 $1.54 $0.05 $0.65

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $12.52B $12.38B $12.87B $12.87B $7.02B
Total Current Assets $2.80B $2.57B $2.89B $2.89B $4.47B
Cash and Cash Equivalents & Short-Term Investments $1.50B $1.52B $1.72B $1.72B $3.41B
-Cash and Cash Equivalents $1.50B $1.52B $1.72B $1.72B $1.76B
Receivables $1.28B $1.03B $1.15B $1.15B $1.05B
-Accounts Receivable $1.21B $968.00M $1.11B $1.11B $1.05B
-Taxes Receivable $68.00M $63.00M $40.00M $40.00M $0.00
Inventory $18.00M $21.00M $18.00M $18.00M $14.00M
Total Non-Current Assets $9.71B $9.80B $9.99B $9.99B $2.55B
Net PPE $254.00M $265.00M $280.00M $280.00M $266.00M
-Gross PPE $254.00M $265.00M $437.00M $437.00M $266.00M
Investments and Advances $36.00M $40.00M $37.00M $37.00M $36.00M
Non Current Accounts Receivables $24.00M – $22.00M $22.00M $9.00M
Goodwill and Other Intangible Assets $9.23B $9.30B $9.48B $9.48B $2.10B
-Goodwill $355.00M $355.00M $355.00M $355.00M $355.00M
-Other Intangible Assets $8.87B $8.95B $9.12B $9.12B $1.75B
Non-Current Deferred Assets $173.00M $173.00M $171.00M $171.00M $127.00M
Total Liabilities $6.56B $6.69B $7.03B $7.03B $1.27B
Total Current Liabilities $1.14B $1.18B $1.43B $1.43B $741.00M
Payables $807.00M $861.00M $1.11B $1.11B $722.00M
-Total Tax Payable $0.00 $0.00 $43.00M $43.00M $120.00M
-Other Payable $807.00M $861.00M $1.07B $1.07B $602.00M
Short-Term Debt and Capital Lease Obligation $312.00M $293.00M $291.00M $291.00M $16.00M
-Current Debt $294.00M $275.00M $273.00M $273.00M –
-Current Capital Lease Obligation $18.00M $18.00M $18.00M $18.00M $16.00M
Current Deferred Liabilities $21.00M $24.00M $24.00M $24.00M $3.00M
Total Non-Current Liabilities $5.42B $5.52B $5.60B $5.60B $529.00M
Long Term Accounts Payable and Other Payables $5.00M $5.00M $5.00M $5.00M $6.00M
Long Term Debt and Capital Lease Obligation $4.96B $5.06B $5.14B $5.14B $126.00M
-Long Term Debt $4.84B $4.93B $5.00B $5.00B –
-Long Term Capital Lease Obligation $120.00M $125.00M $134.00M $134.00M $126.00M
Non-Current Deferred Liabilities $452.00M $453.00M $459.00M $459.00M $397.00M
Total Equity $5.96B $5.68B $5.85B $5.85B $5.75B
Stockholders' Equity $5.96B $5.68B $5.85B $5.85B $5.75B
Capital Stock $10.00M $10.00M $10.00M $10.00M $10.00M
-Common Stock $10.00M $10.00M $10.00M $10.00M $10.00M
Additional Paid-In Capital $1.92B $1.92B $1.92B $1.92B $1.91B
Retained Earnings $4.42B $4.09B $4.10B $4.10B $4.03B
Gains/Losses Not Affecting Retained Earnings -$397.00M -$340.00M -$181.00M -$181.00M -$204.00M
Other Non-Current Assets – $22.00M – – $9.00M
-Short Term Investments – – $0.00 $0.00 $1.65B
-Accumulated Depreciation – – -$157.00M -$157.00M –

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $51.00M $3.00M $1.19B $301.00M $536.00M
Net cash flow from continuing operations $51.00M $3.00M $1.19B $301.00M $536.00M
Net Income from Continuing Operations $295.00M $74.00M $1.20B $55.00M $482.00M
Gain/Loss from Continuing Operations $6.00M $8.00M -$62.00M $7.00M $6.00M
Depreciation & Depletion & Amortization $26.00M $29.00M $71.00M $21.00M $18.00M
Other Non-Cash Items $74.00M $98.00M -$77.00M -$4.00M -$29.00M
Change in Working Capital -$267.00M -$113.00M $225.00M $253.00M $2.00M
-Change in Receivables -$259.00M $158.00M -$166.00M -$42.00M -$47.00M
-Change in Inventory $3.00M -$3.00M -$9.00M -$4.00M -$1.00M
-Change in Payables and Accrued Expense -$8.00M -$261.00M $400.00M $299.00M $50.00M
-Change In Other Working Capital -$3.00M -$7.00M – – –
Net cash flow from investing $2.00M -$9.00M -$5.64B -$5.57B -$54.00M
Net Cash Flow from Continuing Investing Activities $2.00M -$9.00M -$5.64B -$5.57B -$54.00M
Net PPE Purchase and Sale -$2.00M -$5.00M -$37.00M -$13.00M -$2.00M
Net Intangibles Purchase and Sale -$1.00M $0.00 -$18.00M $0.00 $0.00
Net Investment Purchase and Sale $0.00 -$4.00M $1.63B $1.66B -$52.00M
Financing Cash Flow -$75.00M -$177.00M $4.79B $5.23B -$21.00M
Net Cash Flow from Continuing Financing Activities -$75.00M -$177.00M $4.79B $5.23B -$21.00M
Net Issuance Payments Of Debt -$65.00M -$69.00M -$13.00M -$2.00M -$5.00M
Net Common Stock Issuance $0.00 -$96.00M $5.07B $5.50B -$24.00M
Proceeds from Stock Option Exercised $1.00M $2.00M $23.00M $7.00M $9.00M
Net Other Financing Charges -$11.00M -$14.00M -$291.00M -$276.00M -$1.00M
Ending Cash Balance $1.50B $1.52B $1.72B $1.72B $1.76B
Net Change in Cash -$22.00M -$183.00M $332.00M -$42.00M $461.00M
Beginning Cash Balance $1.52B $1.72B $1.38B $1.76B $1.30B
Effect of Exchange Rate Changes $4.00M -$11.00M $3.00M -$4.00M $4.00M
Free Cash Flow $48.00M -$2.00M $1.13B $288.00M $534.00M
Net Business Purchase and Sale – – $0.00 $0.00 –
Net Other Investing Changes – – -$7.22B – –

Discussion

No comments yet — be the first to weigh in on GMAB.

Leave a comment

Scroll to Top